Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy Divis Lab at Rs. 629/ share in 2017?

Astec Lifesciences informs about post open offer status

16 Dec 2015

Kotak Mahindra Capital Company (‘Manager to the Offer’), on behalf of Godrej Agrovet (‘Acquirer’) has informed this Post Offer Announcement to the Equity Shareholders of Astec Lifesciences (‘Target Company’), pursuant to and in accordance with regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto (‘SEBI (SAST) Regulations’) in respect of the open offer (‘Offer’) to acquire up to 5,067,259 fully paid up equity shares of Rs 10 each (‘Shares’) of the Target Company. The detailed public statement (‘DPS’) with respect to the Offer was made on September 04, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Astec Lifesciences Ltd. Links:

Astec Lifesciences Share Price

1235.10 17.60 (1.45%) Oct 22, 18:01
1 Year Price Chart
Company Name CMP
UPL 704.40
BASF India 3342.45
PI Industries 3031.80
Bayer CropScience 5029.30
Sumitomo Chemical India 389.25
View more..
Sensex vs Astec Lifesciences
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323